| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10302500 | Journal of Psychiatric Research | 2013 | 6 Pages |
Abstract
Cannabis withdrawal is a clinically significant feature of cannabis use among people with schizophrenia, may serve as a negative reinforcer for relapse, and deserves greater attention in treatment and research. Clinical Trials registration NCT00679016.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Douglas L. Boggs, Deanna L. Kelly, Fang Liu, Jared A. Linthicum, Hailey Turner, Jennifer R. Schroeder, Robert P. McMahon, David A. Gorelick,